July 16, 2009 — Telmisartan and candesartan may not prevent renal disease or microalbuminuria, according to the results of 2 separate studies reported in the July 7 issue of the Annals of ...

In this latest study of diabetic patients treated with ARBs, candesartan was associated with a significant risk of cancer, while there was a trend toward an increased risk with telmisartan. The ...

Two drugs, telmisartan and valsartan, which are used to reduce blood pressure in people with diabetes, are associated with a lower risk of hospitalization for heart attack, stroke or heart failure ...

Patients with vascular disease or high-risk diabetes who are unable to tolerate ACE inhibitors may have experience reduced CV death, MI or stroke with telmisartan treatment. Koon K. Teo, MD, PhD ...

Telmisartan was administered to renovascular ... these results and those obtained with telmisartan may reside in the differences between the mechanisms of action of telmisartan and candesartan.

Additionally, data analysed in the study was limited to three out of seven FDA approved ARBs (telmisartan, losartan, and candesartan), so it is unknown if the other ARBs (valsartan, irbesartan, ...

Boehringer Ingelheim affirms safety of telmisartan with an analysis of 50,000 patients and strongly disagrees with the publication of Sipahi et al in Lancet Oncology June 2010 June 13, 2010 05:19 ...

Methods: We conducted a population-based, retrospective cohort study of Ontario residents with diabetes aged 66 years and older who started treatment with candesartan, irbesartan, losartan, ...

Level 1: Likely reliable evidence A combination of ramipril (Altace) 10 mg daily plus telmisartan (Micardis) 80 mg daily does not reduce mortality or cardiovascular morbidity compared with ...